  The untenable dependence of cryopreservation on cytotoxic cryoprotectants has
motivated the mining of biochemical libraries to identify molecular features
marking cryoprotectants that may prevent ice crystal growth. It is hypothesized
that such molecules may be useful across all temperatures eliminating cellular
destruction due to equilibration cytotoxicity before and after
cryopreservation. By probing the biochemical space using solvation-associated
molecular topology and partition-distribution measures we developed an analytic
formalism for ice crystal inhibition. By probing the union between a heat-shock
protein cluster and an anti-freeze glycoprotein cluster, the model development
process generated distinct regions of interest for anti-freeze glycoprotein and
proved robust across different classes of proteins. These results confirm that
there is a chemical space within which efficacious Ice Crystal Inhibitor
molecular libraries can be constructed. These spaces contain latent projections
drawn from solvent accessibility, hydrogen bonding capacity and molecular
geometry. They also showed that molecular design can be a useful tool in the
development of new-age cryoactive matrices to enable the smooth transition
across culture, preservation and expansion. These chemical spaces provide low
cytotoxicity since such amphipathic molecules occupy a continuum between
solubizing and membrane stabilizing regions as shown by the free energy of
translocation calculations. These biochemical design spaces are fundamentally
the solution to efficient scale-up and deployment of cell therapies.
Consequently, this article proposes the use of a molecular knowledge-mining
approach in the development of a class of non-cytotoxic cryoprotective agents
in the class of Ice Crystal Inhibitor compatible with continuous cryothermic
and normothermic cell storage and expansion.
